Buscopan labeled with carbon-14 and deuterium

被引:5
|
作者
Latli, Bachir [1 ]
Stiasni, Michael [2 ]
Hrapchak, Matt [1 ]
Li, Zhibin [1 ]
Grinberg, Nelu [1 ]
Lee, Heewon [1 ]
Busacca, Carl A. [1 ]
Senanayake, Chris H. [1 ]
机构
[1] Boehringer Ingelheim Pharmaceut Inc, Chem Dev, 900 Ridgebury Rd,POB 368, Ridgefield, CT 06877 USA
[2] Boehringer Ingelheim GmbH & Co KG, Binger Str 173, D-55216 Ingelheim, Germany
关键词
Buscopan; carbon-14; deuterium; hyoscine butyl bromide; radiosynthesis; tropic acid; TROPIC ACID; TROPANE ALKALOIDS; HYOSCINE BUTYLBROMIDE; KINETIC RESOLUTION; DERIVATIVES; ATROPINE; STEREOCHEMISTRY; BIOSYNTHESIS;
D O I
10.1002/jlcr.3463
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Hyosine butyl bromide, the active ingredient in Buscopan, is an anticholinergic and antimuscarinic drug used to treat pain and discomfort caused by abdominal cramps. A straightforward synthesis of carbon-14- and deuterium-labeled Buscopan was developed using scopolamine, n-butyl-1-C-14 bromide, and n-butyl-H-2(9) bromide, respectively. In a second carbon-14 synthesis, the radioactive carbon was incorporated in the tropic acid moiety to follow its metabolism. Herein, we describe the detailed preparations of carbon-14- and deuterium-labeled Buscopan.
引用
收藏
页码:557 / 564
页数:8
相关论文
共 50 条
  • [41] Preparation of carbon-14 labeled organophosphate pesticides: Chlorfenvinphos
    Fudala, L
    Lewin, AH
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 1998, 41 (04): : 261 - 266
  • [42] Carbon-13 and carbon-14 labeled dabigatran etexilate and tritium labeled dabigatran
    Latli, Bachir
    Kiesling, Ralf
    Assfalg, Stefan
    Chevliakov, Max
    Hrapchak, Matt
    Campbell, Scot
    Gonnella, Nina
    Busacca, Carl A.
    Senanayake, Chris H.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2016, 59 (14): : 648 - 656
  • [43] Sodium-Proton Exchanger Isoform-1: Synthesis of a Potent Inhibitor Labeled with Deuterium and Carbon-14
    Latli, Bachir
    Haddad, Nizar
    Hrapchak, Matt
    Wei, Xudong
    Tang, Wenjun
    Song, Jinhua J.
    Senanayake, Chris H.
    CURRENT RADIOPHARMACEUTICALS, 2013, 6 (01) : 7 - 11
  • [44] Synthesis of deuterium, tritium, and carbon-14 labeled BIRB 796, a p38 MAP kinase inhibitor
    Latli, B
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2004, 47 (12): : 847 - 856
  • [45] A GAS-COUNTING METHOD FOR DETERMINATION OF CARBON-14 OF PROTEINS LABELED WITH BOTH CARBON-14 AND IODINE-131
    SALO, T
    BLAIR, B
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1960, 86 (01) : 10 - 15
  • [46] Synthesis of carbon-14 labeled (±) 15-deoxyspergualin trihydrochloride
    Bristol-Myers Squibb, Pharmaceutical Research Institute, 5 Research Parkway, Wallingford, CT 06492, United States
    Journal of Labelled Compounds and Radiopharmaceuticals, 1995, 36 (11): : 1097 - 1103
  • [47] Synthesis of Stable Isotope, Tritiated, and Carbon-14 Labeled Balcinrenone
    Bergare, Jonas
    Bailey, Christopher
    Sorensen, Henrik
    Gronberg, Gunnar
    Broberg, Karl
    Berglund, Monica
    Grecu, Tudor
    Sanchez, Carolina
    Emtenas, Hans
    Bragg, Ryan A.
    Elmore, Charles S.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2024, 67 (04): : 145 - 153
  • [48] Synthesis of imatinib, a tyrosine kinase inhibitor, labeled with carbon-14
    Kang, Julie
    Lee, Jun Young
    Park, Jeong-Hoon
    Chang, Dong-Jo
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2020, 63 (04): : 174 - 182
  • [49] ABSORPTION OF CARBON-14 LABELED LIDOCAINE THROUGH ORAL MUCOSA
    BERGMAN, S
    SIEGEL, IA
    CIANCIO, S
    JOURNAL OF DENTAL RESEARCH, 1968, 47 (6P2) : 1184 - &
  • [50] Synthesis of carbon-14 labeled antioxidant pyrrolopyrimidine compounds.
    Stolle, WT
    Hsi, RSP
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 211 : 216 - MEDI